On May 12, 2020, Minerva Surgical, Inc, acquired the following Intrauterine Health products from Boston Scientific: the Symphion™ Tissue Removal System; the Resectr™ Tissue Resection Device; and the Genesys HTA™ System.  For more information, please visit Minerva Surgical or email meetminerva@minervasurgical.com.

Gynecology

Whether treating menorrhagia or removing fibroids and polyps, we know only one thing matters to you: helping your patients get back to their lives. Our gynecology portfolio includes three minimally invasive surgical solutions: Genesys HTA™ System, Symphion™ System and Resectr™ Tissue Resection Device. Together, they give you the flexibility you need to see and treat these uterine conditions.

Procedures & Treatments, Our minimally invasive procedures such as hysteroscopic tissue removal and endometrial ablation can effectively treat menorrhagia— abnormal uterine bleeding—or remove abnormal uterine growths, such as fibroids and polyps.
Products, From the Genesys HTA™ System to the Resectr™ Tissue Resection Device, we have a range of versatile products that treat challenging uterine conditions.
Additional Resources, If you have any questions about reimbursement or just need to speak with one of our customer service representatives, please visit us at the resources page.
Talk to a representative

Talk to a representative

Want to learn more about products and services? One of our sales representatives will be happy to contact you.

Button
Get updates

Get updates
 

Stay up-to-date with emails on the latest advances, news and innovations.

Button
Visit us on YouTube

Visit us
on YouTube

Get in-depth information on procedures, products and patient resources, featuring “before and after” stories.

Button

References

  1. ACOG Patient FAQ Endometrial Ablation, https://www.acog.org/~/media/For%20Patients/faq134.pdf. Accessed February 19, 2016.
  2. Reilly GP, Savells A. Can endometrial ablation technique effectiveness be properly compared without considering the uteruses treated? A retrospective review of 172 cases of HTA, Novasure and ThermaChoice. J Minim Invasive Gynecol. 2008 Nov-Dec;15(6 Suppl):23S.

Top